Drupal-Biblio17<style face="normal" font="default" size="100%">Investigation of phosphoproteome in RAGE signaling</style>Drupal-Biblio5<style face="normal" font="default" size="100%">Conformational dynamics of intracellular tau protein revealed by cd and saxs</style>
Drupal-Biblio17<style face="normal" font="default" size="100%">Multi-faceted role of melatonin in neuroprotection and amelioration of tau aggregates in alzheimer's disease</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Prion-like propagation of post-translationally modified tau in alzheimer's disease: a hypothesis</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Tau protein squired by molecular chaperones during alzheimer's disease</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Baicalein suppresses repeat tau fibrillization by sequestering oligomers</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Microglial priming of antigen presentation and adaptive stimulation in Alzheimer's disease</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Molecular cobalt(II) complexes for tau polymerization in Alzheimer's disease</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Photoexcited toluidine blue inhibits tau aggregation in Alzheimer's disease</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Protein-capped metal nanoparticles inhibit tau aggregation in alzheimer's disease</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Actin-mediated microglial chemotaxis via G-protein coupled purinergic receptor in alzheimer's disease</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Autophagic pathways to clear the tau aggregates in alzheimer's disease</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Basic limonoid modulates chaperone-mediated proteostasis and dissolve Tau fibrils</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Cobalt-based metal complexes prevent repeat tau aggregation and nontoxic to neuronal cells</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Effect of melatonin on tau aggregation and tau-mediated cell surface morphology</style>Drupal-Biblio17<style face="normal" font="default" size="100%">EGCG impedes human Tau aggregation and interacts with Tau</style>Drupal-Biblio17<style face="normal" font="default" size="100%">G-protein coupled receptors and tau-different roles in alzheimer's disease</style>Drupal-Biblio17<style face="normal" font="default" size="100%">HDAC6 ZnF UBP as the modifier of tau structure and function</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Interaction of Tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Melatonin interacts with repeat domain of Tau to mediate disaggregation of paired helical filaments</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Melatonin reduces GSK3 beta-mediated tau phosphorylation, enhances Nrf2 nuclear translocation and anti-inflammation</style>Drupal-Biblio17<style face="normal" font="default" size="100%">P301 L, an FTDP-17 mutant, exhibits enhanced glycation in vitro</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Phagocytosis of full-length Tau oligomers by Actin-remodeling of activated microglia</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Photodynamic exposure of Rose-Bengal inhibits Tau aggregation and modulates cytoskeletal network in neuronal cells</style>Drupal-Biblio5<style face="normal" font="default" size="100%">Protein misfolding and aggregation of tau protein in alzheimer’s disease</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Residue-based propensity of aggregation in the Tau amyloidogenic hexapeptides AcPHF6*and AcPHF6</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Role of dietary fatty acids in microglial polarization in Alzheimer's disease</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Role of microglia in regulating cholesterol and tau pathology in alzheimer's disease</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Transition metal nickel prevents Tau aggregation in Alzheimer's disease</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Alpha-Linolenic acid inhibits Tau aggregation and modulates Tau conformation</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Alpha-Linolenic acid modulates phagocytosis and endosomal pathways of extracellular Tau in microglia</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Amyloid-beta-derived peptidomimetics inhibits tau aggregation</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Autophagic pathways to clear the tau aggregates in alzheimer’s disease</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Epigallocatechin-3-gallate modulates tau post-translational modifications and cytoskeletal network</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Extracellular HDAC6 ZnF UBP domain modulates the actin network and post-translational modifications of Tau</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Implications of valosin-containing protein in promoting autophagy to prevent tau aggregation</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Influence of sodium caseinate, maltodextrin, pectin and their Maillard conjugate on the stability, in vitro release, anti-oxidant property and cell viability of eugenol-olive oil nanoemulsions</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer's disease</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Microglial remodeling of actin network by Tau oligomers, via G protein-coupled purinergic receptor, P2Y12R-driven chemotaxis</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Neem derivatives inhibits tau aggregation</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Phosphoinositides signaling modulates microglial actin remodeling and phagocytosis in Alzheimer's disease</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Photodynamic sensitizers modulate cytoskeleton structural dynamics in neuronal cells</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Photodynamic treatment modulates various GTPase and cellular signalling pathways in Tauopathy</style>Drupal-Biblio17<style face="normal" font="default" size="100%">G-protein coupled purinergic P2Y12 receptor interacts and internalizes Tau(RD)-mediated by membrane-associated actin cytoskeleton remodeling in microglia</style>Drupal-Biblio17<style face="normal" font="default" size="100%">G-protein coupled purinergic P2Y12 receptor interacts and internalizes TauRD-mediated by membrane-associated actin cytoskeleton remodeling in microglia</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Histone deacetylase-6 modulates Tau function in Alzheimer's disease</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Role of cysteines in accelerating Tau filament formation</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Bacopa monnieri reduces Tau aggregation and Tau-mediated toxicity in cells</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Inhibitory effect of curcumin-artemisinin co-amorphous on Tau aggregation and Tau phosphorylation</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Microglia degrade Tau oligomers deposit via purinergic P2Y12-associated podosome and filopodia formation and induce chemotaxis</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Tau aggregates improve the Purinergic receptor P2Y12-associated podosome rearrangements in microglial cells</style>Drupal-Biblio17<style face="normal" font="default" size="100%">TGF-beta 1 signalling in Alzheimer's pathology and cytoskeletal reorganization: a specialized Tau perspective</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Dual modification of tau by pseudophosphorylation and glycation does not enhance amorphous aggregation</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Macrocyclic peptides derived from AcPHF6*and AcPHF6 to selectively modulate the Tau aggregation</style>